MEDTR.E — Meditera Tibbi Malzeme Sanayi ve Ticaret AS Share Price
- TRY3.94bn
- TRY3.61bn
- TRY1.45bn
- 82
- 27
- 28
- 39
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.67 | ||
Price to Tang. Book | 2.67 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 2.71 | ||
EV to EBITDA | 12.4 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 16.76% | ||
Return on Equity | 1.74% | ||
Operating Margin | 18.56% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | TRYm | 232.09 | 359.32 | 375.93 | 1,595.74 | 1,452.27 | n/a | n/a | 48.75% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +16.76 | +369.3 | +174.54 | -34.91 | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Meditera Tibbi Material Industry and Trade AS is a Turkey-based company, which engages in medical equipment manufacturing. The main activities of the entity consist of manufacturing and sale of medical devices (respiratory systems and infusion systems), drug preparation systems, surgical sutures (surgical sutures), biocidal products and other medical supplies. In addition to all the Company offers necessary technical service, consultancy and training. Meditera produces in its 14,840 square meter production facility with an annual capacity of 4,437 pallets and exports its products to more than 80 countries. The Company, Internacional Farmaceutica S.A. de C.V. S & Mohr company, which was established as a joint venture with (IFSA) company, manufactures surgical sutures in its facilities in Turkey, and S & Mohr America manufactures breathing circuits and accessories in its facilities in Mexico.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 14th, 1996
- Public Since
- July 2nd, 2021
- No. of Employees
- 728
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Istanbul Stock Exchange
- Shares in Issue
- 117,683,797
- Address
- Tire OSB, IZMIR, 35900
- Web
- https://www.meditera.com.tr
- Phone
- +90 2325135110
- Auditors
- HSY Danismanlik ve Bagimsiz Denetim Anonim Sirketi
Upcoming Events for MEDTR.E
Similar to MEDTR.E
Fonet Bilgi Teknolojileri AS
Istanbul Stock Exchange
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS
Istanbul Stock Exchange
Seyitler Kimya Sanayi AS
Istanbul Stock Exchange
FAQ
As of Today at 19:14 UTC, shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS are trading at TRY33.48. This share price information is delayed by 15 minutes.
Shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS last closed at TRY33.48 and the price had moved by +3.02% over the past 365 days. In terms of relative price strength the Meditera Tibbi Malzeme Sanayi ve Ticaret AS share price has underperformed the FTSE Global All Cap Index by -3.29% over the past year.
There is no consensus recommendation for this security.
The Meditera Tibbi Malzeme Sanayi ve Ticaret AS dividend yield is 0.88% based on the trailing twelve month period.
Last year, Meditera Tibbi Malzeme Sanayi ve Ticaret AS paid a total dividend of TRY0.29, and it currently has a trailing dividend yield of 0.88%. We do not have any data on when Meditera Tibbi Malzeme Sanayi ve Ticaret AS is to next pay dividends.
We do not have data on when Meditera Tibbi Malzeme Sanayi ve Ticaret AS is to next pay dividends. The historic dividend yield on Meditera Tibbi Malzeme Sanayi ve Ticaret AS shares is currently 0.88%.
To buy shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of TRY33.48, shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS had a market capitalisation of TRY3.94bn.
Here are the trading details for Meditera Tibbi Malzeme Sanayi ve Ticaret AS:
- Country of listing: Turkey
- Exchange: IST
- Ticker Symbol: MEDTR.E
Based on an overall assessment of its quality, value and momentum Meditera Tibbi Malzeme Sanayi ve Ticaret AS is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Meditera Tibbi Malzeme Sanayi ve Ticaret AS. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -21.75%.
As of the last closing price of TRY33.48, shares in Meditera Tibbi Malzeme Sanayi ve Ticaret AS were trading -7.04% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Meditera Tibbi Malzeme Sanayi ve Ticaret AS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TRY33.48.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Meditera Tibbi Malzeme Sanayi ve Ticaret AS' directors